Showing results (111-120 of 140) with videos related to
Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2017
Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratificationLiming Chen, Piroon Jenjaroenpun, Andrea Mun Ching Pillai, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Durvalumab versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): a multicenter, randomized, phase 2 trialNatalie Y L Ngoi, Chel Hun Choi, Junxian Zhu, et al.Oncotarget|April 28, 2015
Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinomaPrashant Kumar, Sayantani Nandi, Tuan Zea Tan, et al.Nature Communications|September 27, 2019
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progressionWen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, et al.Nature Communications|November 10, 2019
Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progressionWen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, et al.EMBO Molecular Medicine|May 14, 2013
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTuan Zea Tan, Qing Hao Miow, Ruby Yun-Ju Huang, et al.Cancer & Metabolism|June 6, 2019
Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHCGro V Røsland, Sissel E Dyrstad, Deusdedit Tusubira, et al.Cell Death Discovery|September 28, 2021
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancersSer Yue Loo, Nicholas L Syn, Angele Pei-Fern Koh, et al.Cell Reports|September 1, 2021
GAGE mediates radio resistance in cervical cancers via the regulation of chromatin accessibilityDawn Sijin Nin, Caryn Wujanto, Tuan Zea Tan, et al.NPJ Precision Oncology|April 16, 2026
Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancersJie Qing Eu, Nur Afiqah Binte Mohamed Salleh, Jayshree Hirpara, et al.Pageof 14